BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shah E, Pimentel M. Placebo effect in clinical trial design for irritable bowel syndrome. J Neurogastroenterol Motil. 2014;20:163-170. [PMID: 24840369 DOI: 10.5056/jnm.2014.20.2.163] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lembo A, Kuo B, Boinpally R, Li E, Mallick M, Bochenek W, Bartolini W. Randomised clinical trial: effects of MD-7246 on irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 2023;57:192-204. [PMID: 36324245 DOI: 10.1111/apt.17274] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Howell CA, Kemppinen A, Allgar V, Dodd M, Knowles CH, McLaughlin J, Pandya P, Whorwell P, Markaryan E, Yiannakou Y. Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D). Gut 2022;71:2430-8. [PMID: 35760493 DOI: 10.1136/gutjnl-2022-327293] [Reference Citation Analysis]
3 Yang Y, Rao K, Zhan K, Shen M, Zheng H, Qin S, Wu H, Bian Z, Huang S. Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. Front Public Health 2022;10:1022145. [PMID: 36589968 DOI: 10.3389/fpubh.2022.1022145] [Reference Citation Analysis]
4 Stróżyk A, Horvath A, Szajewska H. FODMAP dietary restrictions in the management of children with functional abdominal pain disorders: A systematic review. Neurogastroenterol Motil 2022;34:e14345. [PMID: 35231146 DOI: 10.1111/nmo.14345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peng LH, Fang JY, Dai N, Shen XZ, Yang YL, Sun J, Yang YS. Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub-cohort analysis of a phase III, randomized, double-blind, placebo-controlled trial. J Dig Dis 2022;23:99-110. [PMID: 35019221 DOI: 10.1111/1751-2980.13081] [Reference Citation Analysis]
6 Schoemaker MH, Hageman JHJ, Ten Haaf D, Hartog A, Scholtens PAMJ, Boekhorst J, Nauta A, Bos R. Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial. Nutrients 2022;14:309. [PMID: 35057489 DOI: 10.3390/nu14020309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nordström EA, Teixeira C, Montelius C, Jeppsson B, Larsson N. Lactiplantibacillus plantarum 299v (LP299V®): three decades of research. Benef Microbes 2021;:1-26. [PMID: 34365915 DOI: 10.3920/BM2020.0191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Madsen AMA, Halkjær SI, Christensen AH, Günther S, Browne PD, Kallemose T, Hansen LH, Petersen AM. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study. Scand J Gastroenterol 2021;56:761-9. [PMID: 34000958 DOI: 10.1080/00365521.2021.1915375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Shah ED, Chang L, Salwen-Deremer JK, Gibson PR, Keefer L, Muir JG, Eswaran S, Chey WD. Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis. Am J Gastroenterol 2021;116:748-57. [PMID: 33982945 DOI: 10.14309/ajg.0000000000000989] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
10 Laird KT, Stanton AL. Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial. Complement Ther Clin Pract 2021;43:101374. [PMID: 33826992 DOI: 10.1016/j.ctcp.2021.101374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bosman M, Elsenbruch S, Corsetti M, Tack J, Simrén M, Winkens B, Boumans T, Masclee A, Keszthelyi D. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:459-73. [PMID: 33765447 DOI: 10.1016/S2468-1253(21)00023-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
12 Park EJ, Baek SE, Kim M, Kim AR, Park HJ, Kwon O, Lee JH, Yoo JE. Effects of herbal medicine (Danggwijagyaksan) for treating climacteric syndrome with a blood-deficiency-dominant pattern: A randomized, double-blind, placebo-controlled pilot trial. Integr Med Res 2021;10:100715. [PMID: 33665100 DOI: 10.1016/j.imr.2021.100715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Lembo AJ, Covington PS, Dove LS, Andrae DA. Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials. Neurogastroenterol Motil 2020;32:e13774. [PMID: 31984655 DOI: 10.1111/nmo.13774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kemppinen A, Howell C, Allgar V, Dodd M, Gregson J, Knowles C, McLaughlin J, Pandya P, Whorwell P, Markaryan E, Yiannakou Y. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Trials 2020;21:122. [PMID: 32000822 DOI: 10.1186/s13063-020-4069-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 Wang Y, Zheng F, Liu S, Luo H. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome. Gastroenterol Res Pract 2019;2019:9759138. [PMID: 31885549 DOI: 10.1155/2019/9759138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Martoni CJ, Evans M, Chow CT, Chan LS, Leyer G. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial. J Dig Dis 2019;20:435-46. [PMID: 31271261 DOI: 10.1111/1751-2980.12797] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
17 Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4:675-685. [PMID: 31326345 DOI: 10.1016/s2468-1253(19)30198-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 16.3] [Reference Citation Analysis]
18 Xu D, Chen VL, Steiner CA, Berinstein JA, Eswaran S, Waljee AK, Higgins PDR, Owyang C. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2019;114:1043-50. [PMID: 30908299 DOI: 10.14309/ajg.0000000000000198] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 23.8] [Reference Citation Analysis]
19 Ballou S, Beath A, Kaptchuk TJ, Hirsch W, Sommers T, Nee J, Iturrino J, Rangan V, Singh P, Jones M, Lembo A. Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation. Clin Gastroenterol Hepatol 2018;16:1738-1744.e1. [PMID: 29654913 DOI: 10.1016/j.cgh.2018.04.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
20 Clarke J, Tighe MP. Fifteen-minute consultation on the healthy child: Bowel habit in infants and children. Arch Dis Child Educ Pract Ed 2019;104:114-9. [PMID: 30072449 DOI: 10.1136/archdischild-2018-315162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Saito Y, Mihara T, Oki M, Kumagai T. Effects of heat-killed <i>Lactobacillus casei</i> subsp. <i>casei</i> 327 intake on defecation in healthy volunteers: a randomized, double-blind, placebo-controlled, parallel-group study. Bioscience of Microbiota, Food and Health 2018;37:59-65. [DOI: 10.12938/bmfh.17-025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Henggeler JC, Veríssimo M, Ramos F. Non-coeliac gluten sensitivity: A review of the literature. Trends in Food Science & Technology 2017;66:84-92. [DOI: 10.1016/j.tifs.2017.05.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
23 Burkart TL, Kraus A, Koller B, Natalucci G, Latal B, Fauchère JC, Bucher HU, Rüegger CM; Swiss Epo Neuroprotection Trial Group. Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter? Children (Basel) 2017;4:E43. [PMID: 28556820 DOI: 10.3390/children4060043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Holvoet T, Joossens M, Wang J, Boelens J, Verhasselt B, Laukens D, van Vlierberghe H, Hindryckx P, De Vos M, De Looze D, Raes J. Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating. Gut 2017;66:980-2. [PMID: 27511198 DOI: 10.1136/gutjnl-2016-312513] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
25 Han K, Wang J, Seo JG, Kim H. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. J Gastroenterol 2017;52:432-43. [PMID: 27178566 DOI: 10.1007/s00535-016-1224-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
26 Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol 2017; 23(2): 336-344 [PMID: 28127207 DOI: 10.3748/wjg.v23.i2.336] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
27 Elli L, Tomba C, Branchi F, Roncoroni L, Lombardo V, Bardella MT, Ferretti F, Conte D, Valiante F, Fini L, Forti E, Cannizzaro R, Maiero S, Londoni C, Lauri A, Fornaciari G, Lenoci N, Spagnuolo R, Basilisco G, Somalvico F, Borgatta B, Leandro G, Segato S, Barisani D, Morreale G, Buscarini E. Evidence for the Presence of Non-Celiac Gluten Sensitivity in Patients with Functional Gastrointestinal Symptoms: Results from a Multicenter Randomized Double-Blind Placebo-Controlled Gluten Challenge. Nutrients. 2016;8:84. [PMID: 26867199 DOI: 10.3390/nu8020084] [Cited by in Crossref: 125] [Cited by in F6Publishing: 129] [Article Influence: 17.9] [Reference Citation Analysis]
28 Tenca A, Massironi S, Pugliese D, Consonni D, Mauro A, Cavalcoli F, Franchina M, Spampatti M, Conte D, Penagini R. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring. Neurogastroenterol Motil 2016;28:274-80. [PMID: 26568317 DOI: 10.1111/nmo.12723] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
29 Elli L, Roncoroni L, Bardella MT. Non-celiac gluten sensitivity: Time for sifting the grain. World J Gastroenterol 2015; 21(27): 8221-8226 [PMID: 26217073 DOI: 10.3748/wjg.v21.i27.8221] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
30 Penagini R, Sweis R, Mauro A, Domingues G, Vales A, Sifrim D. Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease. J Neurogastroenterol Motil. 2015;21:265-272. [PMID: 25843078 DOI: 10.5056/jnm14075] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 6.9] [Reference Citation Analysis]
31 Guandalini S, Polanco I. Nonceliac Gluten Sensitivity or Wheat Intolerance Syndrome? The Journal of Pediatrics 2015;166:805-11. [DOI: 10.1016/j.jpeds.2014.12.039] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]